教員紹介

Researchmap

研究内容

論文

1. Full activation of mouse platelets requires an ADP secretion pathway regulated by SERCA3 ATPase-dependent calcium stores　Elaïb Z, Adam F, Berrou E, Bordet JC, Prévost N, Bobe R, Brycka　共著（セカンドオーサー）　Blood. Vol.128 NO.8　2016/06
2. A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation　Adam F, Casari C, Prévost N, Kauskot A, Loubière C, Legendre P, Repérant C, Baruch D, Rosa JP, Bryckaert M, de Groot PG, Christophe OD, Lenting PJ, Denis CV　共著（セカンドオーサー）　Scientific Reports.Vol.6　2016/05
3. Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M　Berrou E, Kauskot A, Adam F, Harel A, Legendre P, Lavenu Bombled C, Rothschild C, Prévost N, Christophe OD, Lenting PJ, Denis CV, Rosa JP, Bryckaert M　共著（セカンドオーサー）　PLoS One.Vol.10 NO.12　2015/12
4. Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in mice　Morioka Y, Casari C, Wohner N, Cho S, Kurata S, Kitano A, Christophe OD, Lenting PJ, Li R, Denis CV, Prévost N　共著（ラストオーサー）　Blood.Vol.123 NO.21　2014/04
    

講演・口頭発表等

1. Expression of von Willebrand factor by tumor cells - Relevance to cancer-associated thrombosis and animal studie　Beuchat Z.，Prévost N.　International Society on Thrombosis and Haemostasis( ISTH )　2019/07
2. Von Willebrand Factor-platelet Microthrombi Phagocytosis by Macrophages as a New Homing Mechanism for Tissue Entry and Fibrosis　Fortna R，Prévost N.　International Society on Thrombosis and Haemostasis( ISTH )　2017/07
3. A novel cleavage-resistant and highly prothrombotic von Willebrand factor mutant　Morioka Y，Casari C， Kurata S，Christophe OD，Denis CV，Prévost N　International Society on Thrombosis and Haemostasis( ISTH )　2013/07
4. Expression of exogenous proteins in plateiets:All you need is Yop　Ｗｏｌｋｅ　Ｓ，　kurata S， Morioka Y，Heesemann J，Cornelis G，Prévost N　International Society on Thrombosis and Haemostasis( ISTH )　2013/07